Lexicon Pharmaceuticals LXRX Effective Income Tax Rate Reconciliation, Percent

Effective Income Tax Rate Reconciliation, Percent at other companies

Century CommunitiesCCS

26.3%+1.0pp

HTF

Heartflow, Inc. Common StockHTFL

0%—

PopularBPOP

16%-4.2pp

Evolution Metals & Technologies Corp. EMAT

0%0.0pp

BeldenBDC

18.7%+2.4pp

ePlusPLUS

28.4%+0.4pp

Other financials

Income statement

See full

Revenue$21.1M+1,572%

Gross profit$21.0M+1,604%

Operating income-$996.0K+96.1%

Net income-$1.0M+95.9%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$67.1M+6.7%

Total debt$57.7M-45.7%

Total equity$202.9M+64.9%

Total assets$268.8M-9.7%

Cash flow

See full

Operating cash flow-$14.7M+66.4%

CapEx--100%

Free cash flow-$17.2M+21.5%

Valuation

See full

Market cap$986.12M+273%

Enterprise value$976.73M+219%

P/S14.2×+5.7×

Profitability

See full

Gross margin99.5%+1.5pp

Operating margin-34.8%-16.8pp

Net margin-37.5%-18.1pp

FCF margin-578.5%-283pp

Returns & leverage

See full

Return on equity-16%-7.2pp

Debt / equity0.3×-0.6×

Current ratio18.8×+16.6×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateContinuingOperations.

The official record: Lexicon Pharmaceuticals’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's effective income tax rate reconciliation, percent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lexicon Pharmaceuticals's effective income tax rate reconciliation, percent?: Lexicon Pharmaceuticals (LXRX) reported effective income tax rate reconciliation, percent of $0 in Q4 2025.